PHAR
Pharming Group NV
NASDAQ: PHAR · HEALTHCARE · BIOTECHNOLOGY
$16.36
-0.40% today
Updated 2026-04-29
Market cap
$1.16B
P/E ratio
408.88
P/S ratio
3.07x
EPS (TTM)
$0.04
Dividend yield
—
52W range
$9 – $21
Volume
0.0M
Pharming Group NV (PHAR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+180.0%
Last 4 quarters
Revenue YoY growth
-99.9%
Most recent quarter
EPS YoY growth
+1300.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+3.0%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+9.1%
2025-10-22
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-12 | $0.07 | +498.3% | $15.88 | $14.51 | -8.6% |
| 2025-10-22 | $0.10 | +180.0% | $13.57 | $14.81 | +9.1% |
| 2025-07-31 | $0.01 | +180.0% | $10.09 | $10.96 | +8.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.01 | $0.07 | +498.3% | $106.39M | -99.9% |
| 2025-09-30 | $-0.13 | $0.10 | +180.0% | $97.29M | +30.0% |
| 2025-06-30 | $-0.01 | $0.01 | +180.0% | $93.22M | +25.9% |
| 2025-03-31 | $-0.03 | $-0.02 | +12.0% | $79.09M | +42.3% |
| 2024-12-31 | $0.01 | $0.01 | -41.2% | $92.70B | +113132.8% |
| 2024-09-30 | $-0.00 | $-0.02 | -512.0% | $74.85M | +12.3% |
| 2024-06-30 | $-0.00 | $-0.02 | -785.0% | $74.03M | +34.9% |
| 2024-03-31 | $0.01 | $-0.19 | -2744.3% | $55.59M | — |
| 2023-12-31 | $0.00 | $-0.04 | -1002.2% | $81.87M | — |
| 2023-09-30 | $0.01 | $0.01 | -50.0% | $66.66M | — |
| 2023-06-30 | $0.01 | $0.01 | +0.0% | $54.90M | — |
Frequently asked questions
Has Pharming Group NV beaten earnings estimates?
Pharming Group NV has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +180.0% over the last 1 quarters.
How does PHAR stock react to earnings?
PHAR stock has moved an average of +3.0% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Pharming Group NV's revenue growth rate?
Pharming Group NV reported year-over-year revenue growth of -99.9% in its most recent quarter, with EPS growing +1300.0% year-over-year.